- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about CRSP
Recent news which mentions CRSP
3 Stocks Cathie Wood Is Buying That You Might Want to Consider Too
October 26, 2021
From Motley Fool
Biotech Buyouts That Would Be Great for Investors
October 22, 2021
From Motley Fool
3 of the Best Stocks to Buy Now With $500
October 22, 2021
From Motley Fool
3 Things About CRISPR Therapeutics That Smart Investors Know
October 20, 2021
From Motley Fool
If You Invested $5,000 in Vertex Pharmaceuticals In 2016, This Is How Much You Would Have Today
October 19, 2021
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2021
October 19, 2021
From Benzinga
From Motley Fool
2 Tricks and a Treat for Gene Therapy Investors
October 18, 2021
From Motley Fool
2 Gene-Editing Stocks to Have on Your Radar Right Now
October 17, 2021
From Motley Fool
2 Top Healthcare Stocks That Could Be Bought Out in 2022
October 16, 2021
From Motley Fool
If You Invested $3,000 in CRISPR Therapeutics in 2018, This Is How Much You Would Have Today
October 16, 2021
From Motley Fool
3 No-Brainer Biotech Stocks to Buy Right Now
October 16, 2021
From Motley Fool
BZ Chart Of The Day: Is Crisper Therapeutics About To Rally?
October 15, 2021
Tickers
CRSP
From Benzinga
Why Shares of Allogene Therapeutics, Beam Therapeutics, Intellia Therapeutics, and Schrödinger Are Volatile This Week
October 15, 2021
From Motley Fool
3 Highly Profitable Stocks Wall Street Thinks Will Soar 39% or More
October 15, 2021
From Motley Fool
From Benzinga
50 Biggest Movers From Yesterday
October 14, 2021
From Benzinga
From InvestorPlace
From InvestorPlace
From InvestorPlace
40 Stocks Moving In Wednesday's Mid-Day Session
October 13, 2021
From Benzinga
Why CRISPR Therapeutics Stock Is Sinking Today
October 13, 2021
From Motley Fool
The Daily Biotech Pulse: FDA Nod For Lilly, Regulus Slumps On Study Discontinuation, ObSeva Strikes Linzagolix Commercialization Deal
October 13, 2021
From Benzinga
From InvestorPlace
20 Stocks Moving in Wednesday's Pre-Market Session
October 13, 2021
From Benzinga
3 Biotech Stocks You Can Buy and Hold for the Next Decade
October 13, 2021
From Motley Fool
How to Invest in Biotech Stocks in a Bear Market
October 13, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.